Table 2.
The likelihood of being diagnosed as having early-stage disease* estimated by crude and adjusted regression models with ORs and 95% CIs
| N (%) | Crude |
Adjusted |
|||
| OR | 95% CI | OR | 95% CI | ||
| Socioeconomic quintile | |||||
| Q1 (affluent) | 236 (15.4) | 1.00 | Reference | 1.00 | Reference |
| Q2 | 341 (18.6) | 1.25 | 1.04 to 1.50 | 1.24 | 1.04 to 1.49 |
| Q3 | 369 (16.9) | 1.12 | 0.93 to 1.34 | 1.11 | 0.93 to 1.33 |
| Q4 | 492 (17.9) | 1.20 | 1.01 to 1.42 | 1.18 | 1.00 to 1.40 |
| Q5 (deprived) | 480 (15.8) | 1.03 | 0.87 to 1.22 | 1.01 | 0.85 to 1.20 |
| Test for trend (χ2, p value) | 0.18 | 0.67 | 0.59 | 0.44 | |
| Sex | |||||
| Male | 1037 (15.9) | 1.00 | Reference | 1.00 | Reference |
| Female | 881 (18.3) | 1.19 | 1.08 to 1.30 | 1.10 | 1.10 to 1.33 |
| Test for trend (χ2, p value) | 11.5 | <0.01 | 12.6 | <0.01 | |
| Age at diagnosis | |||||
| 0–59 | 300 (15.2) | 1.00 | Reference | 1.00 | Reference |
| 60–69 | 550 (17.6) | 1.19 | 1.02 to 1.39 | 1.16 | 0.99 to 1.35 |
| 70–79 | 694 (18.4) | 1.26 | 1.08 to 1.46 | 1.18 | 1.01 to 1.37 |
| 80+ | 374 (15.3) | 1.01 | 0.85 to 1.19 | 0.93 | 0.78 to 1.10 |
| Test for trend (χ2, p value) | 2.75 | 0.10 | 0.29 | 0.59 | |
| Charlson Score | |||||
| 0 | 719 (15.0) | 1.00 | Reference | 1.00 | Reference |
| 1 | 511 (17.6) | 1.19 | 1.05 to 1.34 | 1.19 | 1.05 to 1.34 |
| 2+ | 504 (19.0) | 1.29 | 1.14 to 1.47 | 1.31 | 1.15 to 1.49 |
| Test for trend (χ2, p value) | 20.0 | <0.01 | 21.7 | <0.01 | |
*
The binary outcome was categorised into early-stage disease (stages IA–IIB at diagnosis) or advanced disease (stages IIIA–IV at diagnosis).